Pralidoxime
Duodote, Protopam (pralidoxime) is a small molecule pharmaceutical. Pralidoxime was first approved as Protopam chloride on 1982-01-01. It is used to treat drug overdose and poisoning in the USA. The pharmaceutical is active against acetylcholinesterase.
Download report
Favorite
Commercial
Trade Name
FDA
EMA
Protopam
CombinationsDuodote (discontinued: Atnaa)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| atnaa atropine and pralidoxime chloride | New Drug Application | 2021-11-26 |
| duodote | New Drug Application | 2020-12-10 |
| protopam chloride | New Drug Application | 2018-01-01 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
|---|---|---|---|
| drug overdose | — | D062787 | — |
| poisoning | EFO_0008546 | D011041 | T65.91 |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
Code | Description |
|---|---|
| J2730 | Injection, pralidoxime chloride, up to 1 gm |
Clinical
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | PRALIDOXIME |
| INN | — |
| Description | Pralidoxime is a pyridinium ion that is 1-methylpyridinium substituted by a (hydroxyimino)methyl group at position 2. It has a role as a cholinergic drug, a cholinesterase reactivator, an antidote to organophosphate poisoning and an antidote to sarin poisoning. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | C[n+]1ccccc1C=NO |
Identifiers
| PDB | — |
| CAS-ID | 6735-59-7 |
| RxCUI | 1546365 |
| ChEMBL ID | CHEMBL1420 |
| ChEBI ID | 8354 |
| PubChem CID | 135398747 |
| DrugBank | DB00733 |
| UNII ID | — |
Target
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:

Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 1,026 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions

Mock data
Subscribe for the real data
Subscribe for the real data
3 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more
